Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis
Conclusions:
Tofacitinib may represent a new treatment option for hospitalized pediatric patients with corticosteroid- and anti-TNF-nonresponsive ulcerative colitis. Future research is essential in determining the optimal positioning of these therapies.
Source: Journal of Pediatric Gastroenterology and Nutrition - Category: Gastroenterology Tags: Original Articles: Gastroenterology: Inflammatory Bowel Disease Source Type: research
More News: Children | Colectomy | Corticosteroid Therapy | Gastroenterology | Inflammatory Bowel Disease | Nutrition | Parenteral Nutrition | Pediatrics | Study | Ulcerative Colitis